Document is current
Any future updates will be listed below
-
Authors
Roehrich, Luise https://orcid.org/0000-0002-8826-075X
Hinkov, Hristian https://orcid.org/0000-0002-9602-2794
Knosalla, Christoph https://orcid.org/0000-0002-8127-5019
Hennig, Felix
Klein, Christoph
Kukucka, Marian
Merke, Nicolas
Kopp Fernandes, Laurenz
Just, Isabell Anna
Ott, Sascha
Dreger, Henryk https://orcid.org/0000-0003-1909-4329
Falk, Volkmar https://orcid.org/0000-0002-7911-8620
Unbehaun, Axel
Schoenrath, Felix
- License Information
-
More Information
Article History
Received: 31 January 2025
Accepted: 12 September 2025
First Online: 1 October 2025
Competing interests
: The following authors declare no competing interests: L.R., H.H.i., C.K., F.H., C.K.l., M.K., N.M., L.K.F. The authors declare the following competing interests outside of the submitted work: I.A.J. Speakers honoraria from astrazeneca, Abbott, Abiomed. S.O. received institutional research and study funds from Novartis Pharma GmbH and institutional research, study and educational grants, speaker fees and advisory board fees from Abiomed. H.D. Speaker’s fees, advisory board: Abbott, Edwards; research support: Abbott. V.F. institutional financial activities in relation to the following: educational grants (including travel support), fees for lectures and speeches, fees for professional consultation, and research and study funds with the following commercial entities: Medtronic GmbH, Biotronik S.E. & Co, Abiomed GmbH, Abbott GmbH & Co, KG, Boston Scientific, Edwards Lifesciences, Berlin Heart, Novartis Pharma GmbH, JOTEC/CryoLife GmbH, LivaNova, and Zurich Heart. A.U. Physician proctor to Edwards Lifesciences, Medtronic and JenaValve. F.S. received institutional grants from Novartis, Abbott, non-financial support from Medtronic and institutional fees (speaker honoraria) from Abbott, Bayer, Novartis and Abiomed outside of the submitted work
